HempFusion Corporate Media Kit

24 W W W . H E M P F U S I O N . C O M | H E M P F U S I O N ® P R E S E N T A T I O N PRACTITIONER DIVISION HF LABS & BIOME RESEARCH H F L A B S B I O M E R E S E A R C H UNIQUE MARKET OPPORTUNITY • This channel provides HempFusion and Probulin products with unique access to consumers through doctor or medical professional patient relationships • Highly selective market segment that requires specific experience and specialized products recommended and or prescribed by medical professionals • 11+ products going to market targeting doctor practitioners • Clinical trials in process to capture prescriptive action MARKET SIZE • 27,000 doctor practitioners accessible through 3 distributors (1) • 70,000+ Licensed Chiropractors in the US (2) • Hospitals, Compounding Pharmacies and Free-Standing Dispensaries EXPERIENCED TEAM • Nancy Angelini leads a team of five National Sales Reps dedicated to expanding HempFusion’s business in this segment $2B Addressable Market US spending on pharmaceutical cannabinoids are expected to be $2 billion by 2024 (3) (1) Based on internal figures (2) https://www.acatoday.org/Portals/60/About/Key_Facts_Figures_2019.pdf (3) “CBD: Cannabinoids Escape the Dispensary” by BDSA & Arcview Market Research (September, 2019) R E V E N U E D R I V E R S